Department of Biostatistics, Johns Hopkins University, Maryland, MD, USA.
Clinical Transformation Center, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Contemp Clin Trials. 2024 Oct;145:107646. doi: 10.1016/j.cct.2024.107646. Epub 2024 Jul 30.
In medical research, publication bias (PB) poses great challenges to the conclusions from systematic reviews and meta-analyses. The majority of efforts in methodological research related to classic PB have focused on examining the potential suppression of studies reporting effects close to the null or statistically non-significant results. Such suppression is common, particularly when the study outcome concerns the effectiveness of a new intervention. On the other hand, attention has recently been drawn to the so-called inverse publication bias (IPB) within the evidence synthesis community. It can occur when assessing adverse events because researchers may favor evidence showing a similar safety profile regarding an adverse event between a new intervention and a control group. In comparison to the classic PB, IPB is much less recognized in the current literature; methods designed for classic PB may be inaccurately applied to address IPB, potentially leading to entirely incorrect conclusions. This article aims to provide a collection of accessible methods to assess IPB for adverse events. Specifically, we discuss the relevance and differences between classic PB and IPB. We also demonstrate visual assessment through contour-enhanced funnel plots tailored to adverse events and popular quantitative methods, including Egger's regression test, Peters' regression test, and the trim-and-fill method for such cases. Three real-world examples are presented to illustrate the bias in various scenarios, and the implementations are illustrated with statistical code. We hope this article offers valuable insights for evaluating IPB in future systematic reviews of adverse events.
在医学研究中,发表偏倚(PB)给系统评价和荟萃分析的结论带来了巨大的挑战。经典 PB 相关方法学研究的大部分努力都集中在检查潜在的对接近零或统计学上无显著性结果的研究的抑制。这种抑制很常见,尤其是当研究结果涉及新干预措施的有效性时。另一方面,最近在证据综合界中引起了对所谓的逆发表偏倚(IPB)的关注。在评估不良反应时可能会发生这种情况,因为研究人员可能倾向于显示新干预措施和对照组之间在不良反应方面具有相似安全性特征的证据。与经典 PB 相比,当前文献中对 IPB 的认识要少得多;为经典 PB 设计的方法可能不准确地应用于解决 IPB,从而可能导致完全错误的结论。本文旨在提供一组可用于评估不良反应中 IPB 的方法。具体来说,我们讨论了经典 PB 和 IPB 的相关性和差异。我们还通过针对不良反应量身定制的轮廓增强漏斗图和流行的定量方法(包括 Egger 回归检验、Peters 回归检验和 Trim-and-Fill 方法)进行了直观评估。通过三个真实案例说明了各种情况下的偏差,并通过统计代码说明了实现。我们希望本文为未来评估不良反应的系统评价中的 IPB 提供有价值的见解。